Publications by authors named "Pascal Jezequel"

Claim this Profile
M
Molecular analysis of lung adenocarcinomas from the SAFIR02-Lung cohort reveals new metastasis-associated copy-number alterations including frequent mutant-specific KRAS-allelic imbalance and identifies CDKN2A homozygous deletions as an independent biomarker of poor prognosis.
Abderaouf Hamza, Pierre Gestraud, Maryam Karimi, Alicia Tran-Dien, Laurène Syx

Br J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A DIA-MS-based proteomics approach to find potential serum prognostic biomarkers in glioblastoma patients.
Anne Clavreul, François Guillonneau, Odile Blanchet, Hamza Lasla, Audrey Rousseau

Mol Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HABiC: an algorithm based on the exact computation of the Kantorovich-Rubinstein optimizer for binary classification in transcriptomics.
Chiara Cordier, Pascal Jézéquel, Mario Campone, Fabien Panloup, Agnes Basseville

Bioinformatics· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomics of tumor and serum samples from isocitrate dehydrogenase-wildtype glioblastoma patients: is the detoxification of reactive oxygen species associated with shorter survival?
Anne Clavreul, Catherine Guette, Hamza Lasla, Audrey Rousseau, Odile Blanchet

Mol Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copy number alterations in metastatic and early breast tumours: prognostic and acquired biomarkers of resistance to CDK4/6 inhibitors.
Marie-Paule Sablin, Pierre Gestraud, Sarah Flora Jonas, Constance Lamy, Magali Lacroix-Triki

Br J Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtype.
Pascal Jézéquel, Hamza Lasla, Wilfried Gouraud, Agnès Basseville, Bertrand Michel

Breast Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain Neural Progenitors are New Predictive Biomarkers for Breast Cancer Hormonotherapy.
Agnes Basseville, Chiara Cordier, Fadoua Ben Azzouz, Wilfried Gouraud, Hamza Lasla

Cancer Res Commun· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deformable image registration with deep network priors: a study on longitudinal PET images.
Constance Fourcade, Ludovic Ferrer, Noémie Moreau, Gianmarco Santini, Aislinn Brennan

Phys Med Biol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of inputs for bone lesion segmentation in longitudinal F-FDG PET/CT imaging studies.
Noemie Moreau, Caroline Rousseau, Constance Fourcade, Gianmarco Santini, Ludovic Ferrer, Pascal Jezequel

Annu Int Conf IEEE Eng Med Biol Soc· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of HER2 Status on Pathological Response after Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer.
Camille Domergue, Elodie Martin, Camille Lemarié, Pascal Jézéquel, Jean-Sebastien Frenel

Cancers (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Metabolic, Volumetric and Textural Parameters of Baseline [F]FDG PET/CT in Early Triple-Negative Breast Cancer.
Clément Bouron, Clara Mathie, Valérie Seegers, Olivier Morel, Pascal Jézéquel

Cancers (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rucaparib in patients presenting a metastatic breast cancer with homologous recombination deficiency, without germline BRCA1/2 mutation.
Anne Patsouris, Kadija Diop, Olivier Tredan, Daniel Nenciu, Anthony Gonçalves

Eur J Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automatic Segmentation of Metastatic Breast Cancer Lesions on F-FDG PET/CT Longitudinal Acquisitions for Treatment Response Assessment.
Noémie Moreau, Caroline Rousseau, Constance Fourcade, Gianmarco Santini, Aislinn Brennan

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Interest of the bc-GenExMiner web tool in oncology].
Pascal Jézéquel, Wilfried Gouraud, Fadoua Ben Azzouz, Agnès Basseville, Philippe P Juin

Bull Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Random forest of perfect trees: concept, performance, applications and perspectives.
Jean-Michel Nguyen, Pascal Jézéquel, Pierre Gillois, Luisa Silva, Faouda Ben Azzouz

Bioinformatics· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The EPICURE study: a pilot prospective cohort study of heterogeneous and massive data integration in metastatic breast cancer patients.
Mathilde Colombié, Pascal Jézéquel, Mathieu Rubeaux, Jean-Sébastien Frenel, Frédéric Bigot

BMC Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an absolute assignment predictor for triple-negative breast cancer subtyping using machine learning approaches.
Fadoua Ben Azzouz, Bertrand Michel, Hamza Lasla, Wilfried Gouraud, Anne-Flore François

Comput Biol Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses.
Pascal Jézéquel, Wilfried Gouraud, Fadoua Ben Azzouz, Catherine Guérin-Charbonnel, Philippe P Juin

Database (Oxford)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RE: Immune Checkpoint Profiles in Luminal B Breast Cancer (Alliance).
Pascal Jézéquel, Anne Patsouris, Catherine Guette, Philippe P Juin, Mario Campone

J Natl Cancer Inst· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: CD95L Cell Surface Cleavage Triggers a Prometastatic Signaling Pathway in Triple-Negative Breast Cancer.
Marine Malleter, Sébastien Tauzin, Alban Bessede, Rémy Castellano, Armelle Goubard

Cancer Res· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STING-dependent paracriny shapes apoptotic priming of breast tumors in response to anti-mitotic treatment.
Steven Lohard, Nathalie Bourgeois, Laurent Maillet, Fabien Gautier, Aurélie Fétiveau

Nat Commun· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
iTRAQ-Based Quantitative Proteomic Analysis Strengthens Transcriptomic Subtyping of Triple-Negative Breast Cancer Tumors.
Pascal Jézéquel, Catherine Guette, Hamza Lasla, Wilfried Gouraud, Alice Boissard

Proteomics· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OLFM4 Expression in Ductal Carcinoma In Situ and in Invasive Breast Cancer Cohorts by a SWATH-Based Proteomic Approach.
Isabelle Valo, Pedro Raro, Alice Boissard, Amine Maarouf, Pascal Jézéquel

Proteomics· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications.
Pascal Jézéquel, Olivier Kerdraon, Hubert Hondermarck, Catherine Guérin-Charbonnel, Hamza Lasla

Breast Cancer Res· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on "How the evolution of multicellularity set the stage for cancer".
Pascal Jézéquel, Mario Campone

Br J Cancer· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis